---
title: "Roivant Sciences | 8-K: FY2026 Revenue Misses Estimate at USD 8.26 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287054981.md"
datetime: "2026-05-20T11:16:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287054981.md)
  - [en](https://longbridge.com/en/news/287054981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287054981.md)
---

# Roivant Sciences | 8-K: FY2026 Revenue Misses Estimate at USD 8.26 M

Revenue: As of FY2026, the actual value is USD 8.26 M, missing the estimate of USD 9.045 M.

EPS: As of FY2026, the actual value is USD -0.54, beating the estimate of USD -1.2444.

EBIT: As of FY2026, the actual value is USD -1.107 B.

The provided reference, a Form 8-K filing by Roivant Sciences Ltd., indicates that the company issued a press release on May 20, 2026, announcing its financial results for the fourth quarter and fiscal year ended March 31, 2026. However, the actual financial results, operational metrics, or any outlook/guidance content from this press release are not included within the provided text of this Form 8-K. Consequently, no specific financial or operational metrics, or forward-looking statements can be extracted from this document.

### Related Stocks

- [ROIV.US](https://longbridge.com/en/quote/ROIV.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [GDEV announces results for the first quarter of 2026 | GDEV Stock News](https://longbridge.com/en/news/286909689.md)
- [LOWE'S REPORTS FIRST QUARTER 2026 SALES AND EARNINGS RESULTS | LOW Stock News](https://longbridge.com/en/news/287043063.md)
- [OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026 | OSTX Stock News](https://longbridge.com/en/news/286607728.md)